BULLETIN V2026-1824
RAKOVINA THERAPEUTICS INC. ("RKV")
BULLETIN TYPE: Private Placement-Non-Brokered, Convertible Debenture/s
BULLETIN DATE: May 27, 2026
TSX Venture Tier 2 Company
Financing Type: Non-Brokered Private Placement
Offering: $1,000,000 principal amount of convertible debenture convertible into 5,000,000 Listed Shares with 2,000,000 detachable warrants
Conversion Price: $0.20 per Listed Share
Maturity date: January 28, 2029
Interest rate: 12% per annum
Warrant Exercise Terms: $0.20 per Listed Share exercisable until January 28, 2029
Commissions in Securities: N/A
Disclosure: Refer to the company's news releases dated January 27, 2026, and March 5, 2026.
_______________________________________
|
|
